<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>9</volume><submitter>Li C</submitter><pubmed_abstract>Huang-Lian-Jie-Du decoction (HLJDD) has been widely applied to treat inflammation-associated diseases for thousands of years in China. However, the concrete molecular mechanism of HLJDD in the treatment of rheumatoid arthritis (RA) remains unclear. In this work, network pharmacology and molecular docking were applied to preliminarily analyze the potential active ingredients, drug targets, and related pathways of HLJDD on treating RA. A total of 102 active compounds with corresponding 189 targets were identified from HLJDD, and 41 common targets were further identified by intersecting with RA-related targets. Functional enrichment analysis was performed to screen the biological pathways associated with RA. Ten hub targets were further identified through constructing the protein-protein inte</pubmed_abstract><journal>Frontiers in cell and developmental biology</journal><pagination>740266</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8807552</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>A Preliminary Inquiry Into the Potential Mechanism of Huang-Lian-Jie-Du Decoction in Treating Rheumatoid Arthritis &lt;i>via&lt;/i> Network Pharmacology and Molecular Docking.</pubmed_title><pmcid>PMC8807552</pmcid><pubmed_authors>Pan J</pubmed_authors><pubmed_authors>Li C</pubmed_authors><pubmed_authors>Xu C</pubmed_authors><pubmed_authors>Chen X</pubmed_authors><pubmed_authors>Jin Z</pubmed_authors></additional><is_claimable>false</is_claimable><name>A Preliminary Inquiry Into the Potential Mechanism of Huang-Lian-Jie-Du Decoction in Treating Rheumatoid Arthritis &lt;i>via&lt;/i> Network Pharmacology and Molecular Docking.</name><description>Huang-Lian-Jie-Du decoction (HLJDD) has been widely applied to treat inflammation-associated diseases for thousands of years in China. However, the concrete molecular mechanism of HLJDD in the treatment of rheumatoid arthritis (RA) remains unclear. In this work, network pharmacology and molecular docking were applied to preliminarily analyze the potential active ingredients, drug targets, and related pathways of HLJDD on treating RA. A total of 102 active compounds with corresponding 189 targets were identified from HLJDD, and 41 common targets were further identified by intersecting with RA-related targets. Functional enrichment analysis was performed to screen the biological pathways associated with RA. Ten hub targets were further identified through constructing the protein-protein inte</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021</publication><modification>2026-04-30T03:08:15.484Z</modification><creation>2025-02-19T03:53:36.692Z</creation></dates><accession>S-EPMC8807552</accession><cross_references><pubmed>35127697</pubmed><doi>10.3389/fcell.2021.740266</doi></cross_references></HashMap>